drugset / Trial / NCT01716689

Clinical Study of Metronomic Oral Cyclophosphamide in Patients With Advanced Sarcomas

NCT01716689 ↗

Phase 2 Completed 24 enrolled National Cancer Centre, Singapore
NaSingle-groupOpen-labelTreatment

Summary

This is a single arm phase II clinical study to evaluate the efficacy and safety of metronomic oral cyclophosphamide in elderly and/or pre-treated patients with advanced sarcomas.

Timeline

Start
2012-06
Primary completion
2016-10
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified 50 mg Oral

Indications